Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Noramco Acquires Cambrex Drug Product Business Unit | Contract Pharma

What are you searching for?

Sign in
Breaking News

Noramco Acquires Cambrex Drug Product Business Unit

Will provide API customers of Noramco and Purisys, additional service options including drug product formulation development, and manufacturing.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Noramco, a global active pharmaceutical ingredients (API) manufacturer specializing in controlled substances, has acquired Cambrex Drug Product Business Unit previously known as Halo Pharmaceuticals. The acquisition will provide API customers of Noramco, and its subsidiary Purisys, additional service options such as drug product formulation development, clinical and commercial drug product manufacturing, and packaging from facilities in Mirabel, Québec and Whippany, NJ. Noramco is returning to the Halo Pharmaceutical brand as part of this acquisition.

“This acquisition allows Noramco to provide our customers with more sourcing options beyond APIs, said Noramco CEO Lee Karras. “With these additional capabilities, Noramco/Purisys customers can develop drug product formulations for their APIs for both clinical and commercial purposes. Having previously operated the Halo Pharmaceuticals business, I have a direct appreciation of the capabilities of both sites and look forward to working with existing and future customers while welcoming the almost 400 new employees to the Noramco group of companies.”




Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics